Lyme IgM Band 25

Lyme IgM Band 25 (OspC) is a key serologic marker used in the early diagnosis of Lyme disease through Western blot testing. This article explains the role of Band 25, how it's detected, when it's clinically relevant, and why careful interpretation is critical to avoid misdiagnosis or overtreatment.

What is Lyme IgM Band 25 (OspC)?

In the context of Lyme disease Western blot testing, a "band" represents the detection of antibodies in the patient's serum that bind to a specific protein (antigen) from Borrelia burgdorferi, the bacterium that causes Lyme disease.

Each band appears on the blot at a particular molecular weight, corresponding to a known bacterial protein (e.g., Band 25 = OspC, Band 39 = BmpA, Band 41 = FlaB).

The presence of a band means the patient has antibodies against that specific B. burgdorferi protein, suggesting exposure or infection.

Outer surface protein C (OspC) is a highly immunogenic protein produced by Borrelia burgdorferi early in infection. OspC is one of the three CDC-recognized IgM bands (p25/OspC, p39, and p41) used to help confirm early Lyme disease.

Lyme Disease Serology: Detecting Antibodies to Borrelia burgdorferi

Lyme disease is caused by Borrelia burgdorferi sensu lato group bacteria, transmitted through blacklegged tick bites.

Antibody Response in Lyme Disease

The immune system produces IgM antibodies early in infection, followed by IgG antibodies in later stages. These antibodies are detected through blood-based serologic tests.

Two-Tiered Testing Approach

• ELISA or IFA (Screening Test): Detects general antibodies to B. burgdorferi.
• Western Blot (Confirmatory Test): Identifies antibodies to specific B. burgdorferi proteins. IgM and IgG are tested separately.

IgM Western Blot and Band 25 (OspC)

OspC (p25) is a key early-stage antigen. IgM reactivity to OspC typically appears within 2–3 weeks of infection.

According to CDC criteria, a positive IgM Western blot requires reactivity to at least 2 of the following:

• Band 25 (OspC)
• Band 39 (BmpA)
• Band 41 (FlaB)

When is Lyme IgM Band 25 Testing Relevant?

Lyme Band 25 testing may be important in the following scenarios:

Early Lyme Disease Diagnosis

Band 25 is a useful marker in the first few weeks of infection, especially if erythema migrans (EM) is absent.

Following a Positive or Equivocal ELISA/IFA

In this setting, a Western blot is performed to confirm infection.

Important Note: IgM antibodies, including those to OspC, can persist for months or even years, making results harder to interpret in late stages or post-treatment.

How Western Blot Works

Separate IgM and IgG Blots: The test detects IgM or IgG antibodies to specific bacterial proteins, depending on the disease stage.

Band Detection: A “band” represents the patient's antibody binding to a distinct B. burgdorferi protein. Each band has a molecular weight corresponding to a known antigen (e.g., p25 = OspC, p39 = BmpA, p41 = FlaB).

Testing Procedure for Lyme IgM Band 25

A Western blot is performed to confirm the diagnosis after a positive or equivocal Lyme ELISA or IFA screening. A blood sample is required, typically obtained via venipuncture.

The patient's serum is applied to a strip containing separated Borrelia burgdorferi proteins by molecular weight. If the patient has antibodies to specific bacterial proteins, they bind to these antigens, forming visible "bands" on the strip.

CDC Criteria for a Positive Test

IgM (≤ 4 weeks after symptom onset): Positive if ≥2 of 3 bands are detected:

• Band 25 (OspC)
• Band 39 (BmpA)
• Band 41 (FlaB)

IgG (> 4 weeks after symptom onset): Positive if ≥5 of 10 bands are detected:

• Includes bands such as p18, p25, p28, p30, p39, p41, p45, p58, p66, and p93.

Timing and Interpretation

Early Infection (≤4 weeks): IgM may be detectable, but specificity is lower due to cross-reactivity.

Late Infection (>4 weeks): IgG is more reliable. IgM alone should not be used to support diagnosis ("1-month rule").

• Persistent IgM without IgG does not confirm active disease.

False Positives: IgM reactivity can occur in healthy individuals or those with other infections (e.g., EBV, autoimmune diseases).

What Does the Presence of Lyme IgM Band 25 Mean?

The presence of Lyme IgM band 25 may have the following clinical indications:

Suggestive of Early Lyme Disease

When Band 25 appears alongside at least one other IgM band and symptoms are consistent, it supports early infection.

Requires Clinical Correlation

Diagnosis should also consider symptoms and tick exposure history.

False Positives Can Occur

Cross-reactivity with other infections (e.g., EBV, syphilis) or autoimmune conditions is possible.

Persistent IgM Without IgG

Some patients show long-lasting OspC IgM without progressing to IgG or showing active symptoms—this does not confirm active disease.

What Does the Absence of Lyme IgM Band 25 Mean?

The absence of Band 25 (OspC) on an IgM Western blot does not rule out Lyme disease, especially in the early stages of infection. Antibodies to OspC typically appear within the first few weeks, but if testing is performed too soon after exposure, the immune response may not yet be detectable. 

Additionally, other IgM or IgG bands may still be present and diagnostically relevant. After approximately 4 to 6 weeks of symptoms, IgG Western blot becomes a more reliable tool, as IgG antibodies are more prominent in later stages. 

Therefore, the timing of testing is critical, and clinicians should not dismiss the possibility of Lyme disease based solely on the absence of Band 25, particularly in the context of recent tick exposure and compatible symptoms.

Key Limitations and Clinical Considerations

OspC IgM is sensitive but not specific. The PKKP motif on OspC cross-reacts with human and bacterial proteins, explaining some false positives.

Avoid diagnosing or treating Lyme based solely on Band 25 reactivity without clinical evidence. Repeat antibiotic treatment for persistent IgM without symptoms or IgG is not recommended.

Clinical Takeaway

Lyme IgM Band 25 (OspC) is a sensitive marker of early infection, but not diagnostic on its own. Use CDC criteria, clinical symptoms, and exposure history to guide interpretation and avoid unnecessary treatment. 

IgG testing and imaging may provide better diagnostic clarity in later disease stages or unclear cases.

Order Lyme Disease Testing

Click here to compare testing options for Lyme disease and order testing.